Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from Groupe D'etude des Néoplasies Endocriniennes Multiples Study Group
- PMID: 11572029
- DOI: 10.1007/s00268-001-0046-z
Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from Groupe D'etude des Néoplasies Endocriniennes Multiples Study Group
Abstract
The French and Belgian GENEM study group's multiple endocrine neoplasia type I (MEN-I) database was used to evaluate trends in clinical presentation, surgical treatment of primary hyperparathyroidism (pHPT) (n = 245), and prognostic factors for hypercalcemia correction among 256 MEN-I cases. The patients were retrieved through the GENEM network from various Belgian and French institutions with the help of genetics laboratories. Among the 245 pHPT patients (96%), 42% were men. The mean age at the time of diagnosis was 39.5 +/- 13.3 years. Trends were studied for three periods: before 1986, from 1986 to 1990, and thereafter. After 1990 MEN-I patients were more often diagnosed with isolated pHPT (8%, 11%, 28%, for the three periods, respectively; p = 0.002); it was seen more often in screened patients (31%, 28%, 53%; p = 0.001), more often among those in already known MEN-I families (64%, 45%, 72%; p = 0.005), and among those with lower preoperative calcemia (2.93, 2.87, 2.79 mmol/L; p = 0.001). The age at pHPT diagnosis remained constant throughout the study. The percentage of cervical explorations dropped during the entire study (87%, 87%, 53%; p < 0.0001). After 1985 the percentage of subtotal parathyroidectomies increased (25%, 59%, 51%; p = 0.0004). Pathology disclosed more hyperplasias (59%, 85%, 74%; p = 0.008). Postoperative hypercalcemia decreased (47%, 15%, 19%; p < 0.0001); and postoperative hypocalcemia increased nonsignificantly (5%, 15%, 15%; p = 0.1). Subtotal parathyroidectomy [odds ratio (OR) 13], no MEN-I family background (OR 3), and the most recent study period (> 1985) (OR 3) were significant predictive factors of hypercalcemia correction according to the multivariate analysis. This is the first multicentric study on the management of MEN-I-related pHPT. Immediate postoperative hHPT cure increased, but only 80% of the operated patients were cured after 1990. Fifteen percent were hypocalcemic. Because MEN-I-related hHPT cure remains difficult to achieve, we advocate that subtotal parathyroidectomies be performed in specialized centers.
Similar articles
-
Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs á Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons.World J Surg. 1996 Sep;20(7):808-12; discussion 812-3. doi: 10.1007/s002689900123. World J Surg. 1996. PMID: 8678955
-
Primary hyperparathyroidism in familial multiple endocrine neoplasia type I. Long-term follow-up of serum calcium levels after parathyroidectomy.Am J Med. 1985 Mar;78(3):467-74. doi: 10.1016/0002-9343(85)90340-7. Am J Med. 1985. PMID: 2858157
-
Management of patients and subjects at risk for multiple endocrine neoplasia type 1: MEN 1. GENEM 1. Groupe d'Etude des Néoplasies Endocriniennes Multiples de type 1.Horm Res. 1997;47(4-6):211-20. doi: 10.1159/000185466. Horm Res. 1997. PMID: 9167954 Review.
-
Parathyroid hyperplasia: an unusual cause of neonatal hypercalcemia.Int J Pediatr Otorhinolaryngol. 2001 Dec 1;61(3):253-7. doi: 10.1016/s0165-5876(01)00560-2. Int J Pediatr Otorhinolaryngol. 2001. PMID: 11700196
-
Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2.Surgery. 1993 Dec;114(6):1031-7; discussion 1037-9. Surgery. 1993. PMID: 7903001 Review.
Cited by
-
Multiple endocrine neoplasia type I.Curr Treat Options Oncol. 2002 Aug;3(4):335-48. doi: 10.1007/s11864-002-0033-0. Curr Treat Options Oncol. 2002. PMID: 12074770 Review.
-
Long-Term Surveillance of Treated Hyperparathyroidism for Multiple Endocrine Neoplasia Type 1: Recurrence or Hypoparathyroidism?World J Surg. 2016 Mar;40(3):615-21. doi: 10.1007/s00268-015-3297-9. World J Surg. 2016. PMID: 26541865
-
Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome.Endocrine. 2023 Dec;82(3):480-490. doi: 10.1007/s12020-023-03497-2. Epub 2023 Aug 26. Endocrine. 2023. PMID: 37632635 Review.
-
The Russian registry of primary hyperparathyroidism, latest update.Front Endocrinol (Lausanne). 2023 Jul 3;14:1203437. doi: 10.3389/fendo.2023.1203437. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37465121 Free PMC article.
-
Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT.Ann Surg. 2008 Mar;247(3):501-10. doi: 10.1097/SLA.0b013e31815efda5. Ann Surg. 2008. PMID: 18376196 Free PMC article.